Treatment of Enteric Fever in Children
First-Line Treatment Options
- The American Academy of Pediatrics recommends azithromycin 20 mg/kg/day (maximum 1g/day) orally for 7 days as first-line therapy for enteric fever in children, especially in areas with high fluoroquinolone resistance 1
- Azithromycin has shown a 94% cure rate in children with typhoid fever and has a lower risk of relapse (OR 0.09) compared to ceftriaxone 1
- For severe cases requiring hospitalization, ceftriaxone 50-80 mg/kg/day (maximum 2g/day) intravenously for 5-7 days is recommended 2, 3
Treatment Based on Resistance Patterns
- For fully susceptible S. typhi strains, fluoroquinolones (ofloxacin or ciprofloxacin) may be used, but resistance is increasingly common 1
- In a randomized trial comparing oral cefixime for 7 days with oral ofloxacin for 5 days in children with culture-proven typhoid fever, ofloxacin showed significantly fewer treatment failures and shorter duration of fever 4, 5, 6
- Over 70% of S. typhi isolates in many regions are now resistant to fluoroquinolones, making ceftriaxone or azithromycin better empiric choices 3
Dosing Guidelines
- Azithromycin: 20 mg/kg/day (maximum 1g/day) orally for 7 days 1, 2
- Ceftriaxone: 50-80 mg/kg/day (maximum 2g/day) IV/IM for 5-7 days 3
Special Considerations
- Always obtain blood cultures before starting antibiotics when possible 3
- For patients with clinical features of sepsis, broad-spectrum antimicrobial therapy should be started immediately after collection of blood cultures 1
- Monitor for clinical response, with expected fever clearance within 4-5 days of appropriate therapy 1
Emerging Resistance Patterns
Common Pitfalls to Avoid
- Avoid using ciprofloxacin empirically for cases originating from South Asia due to high resistance rates 1
- Do not rely solely on clinical presentation for diagnosis; obtain cultures whenever possible 3
- Consider local resistance patterns when selecting empiric therapy, as these vary geographically and change over time 2
Empiric Treatment of Enteric Fever Based on Resistance Patterns
Treatment Duration and Monitoring
- Patients treated initially with parenteral antibiotics should be transferred to an oral regimen as soon as clinical improvement occurs and temperature has been normal for 24 hours, and for most patients with uncomplicated enteric fever, 7 days of appropriate antibiotics is recommended 7
Cefixime Dosage for Empirical Treatment of Enteric Fever
First-Line Treatment Options for Enteric Fever
- The American Academy of Pediatrics recommends cefixime at 8 mg/kg/day in a single daily dose as an appropriate oral option for enteric fever treatment, particularly in children over 28 days old 8, 9
Dosing Considerations
- For children, the recommended dosage is 8 mg/kg/day as a single daily dose, according to the American Academy of Pediatrics 8, 9
- For adults, a dosage of 400 mg orally in a single dose is typically recommended, as suggested by the Centers for Disease Control and Prevention 10
Treatment Duration and Monitoring
- The American Academy of Pediatrics recommends a treatment duration of 7-14 days 11
Treatment of Enteric Fever
First-Line Treatment Options
- Azithromycin has shown lower risk of clinical failure (OR 0.48) and shorter hospital stays compared to fluoroquinolones in systematic reviews, according to the Clinical Microbiology and Infection guidelines 12
Second-Line Treatment Options
- Chloramphenicol may be considered as a last-resort option when no other antibiotics are available, according to WHO recommendations 13
Treatment of Enteric Fever
Initial Management
- For suspected enteric fever with sepsis, initiate broad-spectrum antimicrobial therapy immediately after obtaining blood, stool, and urine cultures, then narrow therapy based on susceptibility results, as recommended by the Infectious Diseases Society of America 14
- Infants under 3 months should be treated with a third-generation cephalosporin, according to the Infectious Diseases Society of America 14
Diagnostic Approach
- Always obtain blood cultures before initiating antibiotics when possible, and also collect stool and urine cultures in suspected sepsis cases, as suggested by the Infectious Diseases Society of America 14
- Modify therapy when susceptibility results become available, as recommended by the Infectious Diseases Society of America 14
Monitoring for Complications
- Reassess fluid and electrolyte balance in patients with persistent symptoms, as recommended by the Infectious Diseases Society of America 14
First‑Line Treatment Recommendations for Enteric Fever
Mild to Moderate Uncomplicated Cases
- Azithromycin 20 mg/kg/day (maximum 1 g) orally for 7 days achieves approximately a 94 % cure rate, reduces clinical failure (OR 0.48, 95 % CI 0.26‑0.89) and shortens hospital stay by about 1 day compared with fluoroquinolones. Evidence from a 2024 systematic review. 15
- Azithromycin markedly lowers relapse risk relative to ceftriaxone (OR 0.09, 95 % CI 0.01‑0.70). Evidence from the same 2024 review. 15
Severe Hospitalized Cases
- Ceftriaxone 50‑80 mg/kg/day (maximum 2 g) intravenously for 5‑7 days reduces treatment‑failure risk compared with gatifloxacin in culture‑confirmed enteric fever (HR 0.24, 95 % CI 0.08‑0.73). Evidence from the 2024 systematic review. 15
Updated Guideline Recommendations
- The World Health Organization (WHO) 2024 Essential Medicines guidelines now recommend azithromycin as the preferred first‑line agent for enteric fever, reflecting systematic‑review evidence of its superiority over fluoroquinolones in regions with high resistance. 15
- WHO advises that fluoroquinolones (e.g., ciprofloxacin, ofloxacin) should be used empirically only when susceptibility is confirmed; they should be avoided for infections acquired from areas with >70 % resistance, reserving them for fully susceptible Salmonella Typhi isolates. 15
- WHO recommends discontinuing empiric use of older first‑line agents (chloramphenicol, ampicillin, co‑trimoxazole) because of widespread multidrug resistance. 15